Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 1453204)

Published in J Clin Oncol on December 01, 1992

Authors

L S Lashford1, I J Lewis, S L Fielding, M A Flower, S Meller, J T Kemshead, D Ackery

Author Affiliations

1: Department of Paediatric Oncology, St James's University Hospital, Leeds, United Kingdom.

Articles citing this

Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray". Eur J Nucl Med Mol Imaging (2007) 1.71

Promising therapeutic targets in neuroblastoma. Clin Cancer Res (2012) 1.48

Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma. Nucl Med Biol (2008) 1.35

EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy. Eur J Nucl Med Mol Imaging (2008) 1.33

Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study. J Clin Oncol (2009) 1.11

Prediction of accumulation of 131I-labelled meta-iodobenzylguanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction. Br J Cancer (1994) 0.98

Neuroblastoma. Semin Pediatr Surg (2012) 0.97

131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients. Br J Cancer (1999) 0.93

Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma. Pediatr Blood Cancer (2010) 0.84

Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy. Br J Cancer (2001) 0.83

Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma. Nucl Med Commun (2016) 0.82

Hypertension complicating 131I-meta-iodobenzylguanidine therapy for neuroblastoma. Eur J Nucl Med Mol Imaging (2012) 0.82

Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies. Eur J Nucl Med Mol Imaging (2011) 0.79

Targeted radiotherapy for neuroblastoma. Arch Dis Child (1997) 0.76

Incorporation of high-dose (131)I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study. J Hematol Oncol (2017) 0.75

Evaluation of phenylpiperazines as targeting agents for neuroblastoma. Br J Cancer (1996) 0.75

Management of neuroblastoma: a study of first- and second-line chemotherapy responses, a single institution experience. Oncol Rev (2012) 0.75

Norepinephrine Transporter as a Target for Imaging and Therapy. J Nucl Med (2017) 0.75

Articles by these authors

(truncated to the top 100)

Delayed access to health care: risk factors, reasons, and consequences. Ann Intern Med (1991) 4.51

Screening for asymptomatic urinary-tract infection in schoolgirls. A two-centre feasibility study. Lancet (1973) 3.10

Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer (1983) 2.36

Childhood cancer and ethnic group in Britain: a United Kingdom children's Cancer Study Group (UKCCSG) study. Br J Cancer (1991) 2.33

Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders. Lancet (1983) 2.26

Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis. Br J Radiol (1997) 2.06

Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group. J Clin Oncol (1993) 1.93

Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small-cell lung carcinoma and neuroblastoma. Int J Cancer (1989) 1.85

Transposition of the gene encoding a TEM-12 extended-spectrum beta-lactamase. Antimicrob Agents Chemother (1992) 1.84

Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma. Eur J Cancer (1992) 1.70

Government investment in health care. Sci Am (1971) 1.64

Toward hospital library standards in Canada. Bull Med Libr Assoc (1978) 1.61

Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward. J Antimicrob Chemother (1995) 1.57

Fast accurate iterative reconstruction for low-statistics positron volume imaging. Phys Med Biol (1998) 1.51

Identification of immune system and response genes, and novel mutations causing melanotic tumor formation in Drosophila melanogaster. Genetics (1996) 1.43

Arsenic and Ayurveda. Leuk Lymphoma (1993) 1.43

Curettage after mifepristone-induced abortion: frequency, timing, and indications. Obstet Gynecol (2001) 1.39

Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Int J Cancer (1994) 1.37

Glandular fever-like syndrome, pulmonary eosinophilia and asthma associated with carbamazepine. Postgrad Med J (1982) 1.32

Synovial sarcoma of the heart. Histopathology (1997) 1.31

Rupture of the uterus at New Orleans Charity Hospital. A report of 101 cases and comparison with the previously reported 96 cases. Am J Obstet Gynecol (1970) 1.31

The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur J Cancer (1997) 1.30

Novel non-isotopic in situ hybridization technique detects small (1 Kb) unique sequences in routinely G-banded human chromosomes: fine mapping of N-myc and beta-NGF genes. Nucleic Acids Res (1987) 1.30

Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial. JAMA (2000) 1.28

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Ann Oncol (2011) 1.28

Diarrhoea due to Cryptosporidium in acute lymphoblastic leukemia. Arch Dis Child (1985) 1.22

Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet (1984) 1.22

Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int (2000) 1.20

Disseminated malignant phaeochromocytoma: localisation with iodine-131-labelled meta-iodobenzylguanidine. Br Med J (Clin Res Ed) (1982) 1.16

Conduct of phase I trials in children with cancer. J Clin Oncol (1998) 1.16

Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts. J Neuropathol Exp Neurol (1989) 1.14

Can we say what diet is best for health? Annu Rev Public Health (2014) 1.14

Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma. J Clin Pathol (1989) 1.14

Immunocytochemical detection of tumours of neuroectodermal origin. J Clin Pathol (1988) 1.12

Mitral regurgitation after anthracycline treatment for childhood malignancy. Heart (2001) 1.10

Science and health care--the political problem. N Engl J Med (1969) 1.07

Enteropathy complicating maintenance therapy in acute lymphoblastic leukaemia. Arch Dis Child (1982) 1.05

A combined cytogenetic and molecular approach to diagnosis in a case of desmoplastic small round cell tumor with a complex translocation (11;22;21). Cancer Genet Cytogenet (1999) 1.05

Ethnic group and survival from childhood cancer: report from the UK Children's Cancer Study Group. Br J Cancer (2000) 1.04

Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies. J Natl Cancer Inst (1984) 1.03

Familial microcephaly with normal intelligence in a patient with acute lymphoblastic leukemia. Cancer (1992) 1.03

Magnetic separation techniques: their application to medicine. Mol Cell Biochem (1985) 1.02

Non-specific factor replaces T cells in an IgG response to soluble antigens. Immunology (1977) 1.02

Therapeutic application of a radiolabelled monoclonal antibody in nude mice xenografted with human neuroblastoma: tumoricidal effects and distribution studies. Int J Cancer (1985) 1.02

A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma. Health Technol Assess (2003) 1.01

Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther (1999) 1.01

Use of monoclonal antibody panel to identify malignant cells in cerebrospinal fluid. Lancet (1984) 1.01

Monoclonal antibody UJ 127:11 detects a 220,000-240,000 kdal. glycoprotein present on a sub-set of neuroectodermally derived cells. Int J Cancer (1983) 1.01

Centromeric instability of chromosomes 1 and 16 with variable immune deficiency: a new syndrome. Clin Genet (1985) 1.00

Is coagulase-negative staphylococcal bacteraemia in neonates a consequence of mechanical ventilation? J Hosp Infect (1985) 0.99

Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group. Br J Cancer (1998) 0.99

12q13 abnormality in rhabdomyosarcoma. A nonrandom occurrence? Cancer Genet Cytogenet (1992) 0.98

EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma. Eur J Cancer (1997) 0.98

A pilot study of 131I monoclonal antibodies in the therapy of leptomeningeal tumors. Cancer (1988) 0.98

A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm. J Neurooncol (1991) 0.98

IgG anti-hapten antibody secretion in vitro commences after extensive precursor proliferation. Immunology (1977) 0.98

Immunohistological diagnosis of central nervous system tumours using a monoclonal antibody panel. J Clin Pathol (1985) 0.98

Monoclonal antibody to ganglioside GQ discriminates between haemopoietic cells and infiltrating neuroblastoma tumour cells in bone marrow. Int J Cancer (1981) 0.98

Monoclonal antibodies defining markers with apparent selectivity for particular haemopoietic cell types may also detect antigens on cells of neural crest origin. Hybridoma (1982) 0.97

A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family. Eur J Cancer (2003) 0.97

Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Eur J Cancer (1995) 0.97

Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year. J Clin Oncol (2001) 0.97

Differential chemokine expression in chronic GVHD of the conjunctiva. Bone Marrow Transplant (2010) 0.96

Human Thy-1: expression on the cell surface of neuronal and glial cells. Brain Res (1982) 0.96

L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin. Eur J Immunol (1996) 0.96

Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine. Cancer Res (1988) 0.96

Survival from childhood cancer in Yorkshire, U.K.: effect of ethnicity and socio-economic status. Eur J Cancer (1999) 0.96

Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception (2001) 0.95

Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma. Med Pediatr Oncol (2001) 0.95

Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer (1991) 0.95

Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood (2000) 0.95

Thalidomide treatment for chronic graft-versus-host disease. Br J Haematol (1991) 0.95

Bone marrow examination in neuroblastoma patients: a morphologic, immunocytochemical, and immunohistochemical study. Hum Pathol (1989) 0.95

N-myc amplification in malignant astrocytoma. Lancet (1985) 0.95

Cancer incidence among the south Asian and non-south Asian population under 30 years of age in Yorkshire, UK. Br J Cancer (2010) 0.95

Therapeutic application of radiolabeled monoclonal antibody UJ13A in children with disseminated neuroblastoma. NCI Monogr (1987) 0.94

Degradation of abnormal proteins in Escherichia coli: relative susceptibility of canavanyl proteins and puromycin peptides to proteolysis in vitro. Eur J Biochem (1974) 0.93

Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C). Int J Cancer (1991) 0.93

Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis (1992) 0.93

Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography. Br J Radiol (1992) 0.92

N-myc oncogene amplification in rhabdomyosarcoma at release. Lancet (1986) 0.92

A monoclonal antibody detecting an antigen shared by neural and granulocytic cells. Pediatr Res (1981) 0.92

The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial. Clin Neuropathol (1995) 0.92

Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception (2000) 0.92

Three-dimensional computer vision for tooth restoration. Med Image Anal (1999) 0.92

A monoclonal antibody binding to human medulloblastoma cells and to the platelet glycoprotein IIB-IIIA complex. Br J Haematol (1984) 0.91

A comparison between the use of a shadow shield whole body counter and an uncollimated gamma camera ain the assessment of the seven-day retention of SeHCAT. Br J Radiol (1984) 0.91

Establishing long-term survival and cure in young patients with Ewing's sarcoma. Br J Cancer (2004) 0.91

Spontaneous regression of neonatal fibrosarcoma. Br J Cancer Suppl (1992) 0.91

Long-term survival after spontaneous rupture of a malignant rhabdoid tumor of the liver. J Pediatr Surg (2002) 0.91

The effects of single dose oral hydralazine on blood flow through human lung tumours. Radiother Oncol (1990) 0.91

Mifepristone abortion in minors. Contraception (2001) 0.90

Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations. Br J Cancer (1986) 0.90

Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma. Cancer Res (2000) 0.90

Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission. Bone Marrow Transplant (1996) 0.89

The experimental evaluation of a prototype rotating slat collimator for planar gamma camera imaging. Phys Med Biol (1995) 0.89

The use of monoclonal antibodies for the diagnosis of intracranial malignancies and the small round cell tumours of childhood. J Pathol (1983) 0.89

Comparative studies between a new human rhabdomyosarcoma cell line, JR-1 and its tumour of origin. Br J Cancer (1986) 0.89

Progressive glomerular toxicity of ifosfamide in children. Med Pediatr Oncol (1996) 0.88

Three-dimensional display of data obtained by single photon emission computed tomography. Br J Radiol (1987) 0.88